Wall Street Analysts See a 70.33% Upside in Arcutis Biotherapeutics (ARQT): Can the Stock Really Move This High?

Arcutis Biotherapeutics, Inc. (ARQT) closed the last trading session at $10.82, gaining 10.5% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of$ 18.43 indicates a 70.3% upside potential.The average comprises seven short-term price targets ranging from a low of $11 to a high of$ 26, with a standard deviation of $4.50. While the lowest estimate indicates an increase of 1.7% from the cu ...